Collins SJ - Search Results

1

Antioxidant and Metal Chelation-Based Therapies in the Treatment of Prion Disease.

Brazier MW, Wedd AG, Collins SJ. Brazier MW, et al. Among authors: collins sj. Antioxidants (Basel). 2014 Apr 21;3(2):288-308. doi: 10.3390/antiox3020288. Antioxidants (Basel). 2014. PMID: 26784872 Free PMC article. Review.

2

Sublethal concentrations of prion peptide PrP106-126 or the amyloid beta peptide of Alzheimer's disease activates expression of proapoptotic markers in primary cortical neurons.

White AR, Guirguis R, Brazier MW, Jobling MF, Hill AF, Beyreuther K, Barrow CJ, Masters CL, Collins SJ, Cappai R. White AR, et al. Among authors: collins sj. Neurobiol Dis. 2001 Apr;8(2):299-316. doi: 10.1006/nbdi.2001.0386. Neurobiol Dis. 2001. PMID: 11300725

3

Prions in skeletal muscle.

Brazier MW, Cappai R, Collins SJ. Brazier MW, et al. Among authors: collins sj. Aust Vet J. 2002 Aug;80(8):484-5. doi: 10.1111/j.1751-0813.2002.tb12471.x. Aust Vet J. 2002. PMID: 12224617 No abstract available.

4

Quinacrine does not prolong survival in a murine Creutzfeldt-Jakob disease model.

Collins SJ, Lewis V, Brazier M, Hill AF, Fletcher A, Masters CL. Collins SJ, et al. Ann Neurol. 2002 Oct;52(4):503-6. doi: 10.1002/ana.10336. Ann Neurol. 2002. PMID: 12325081

5

Diverse fibrillar peptides directly bind the Alzheimer's amyloid precursor protein and amyloid precursor-like protein 2 resulting in cellular accumulation.

White AR, Maher F, Brazier MW, Jobling MF, Thyer J, Stewart LR, Thompson A, Gibson R, Masters CL, Multhaup G, Beyreuther K, Barrow CJ, Collins SJ, Cappai R. White AR, et al. Among authors: collins sj. Brain Res. 2003 Mar 21;966(2):231-44. doi: 10.1016/s0006-8993(02)04173-2. Brain Res. 2003. PMID: 12618346

6

Human prion diseases: cause, clinical and diagnostic aspects.

Knight R, Brazier M, Collins SJ. Knight R, et al. Among authors: collins sj. Contrib Microbiol. 2004;11:72-97. doi: 10.1159/000077051. Contrib Microbiol. 2004. PMID: 15077404 Review. No abstract available.

7

Extended period of asymptomatic prion disease after low dose inoculation: assessment of detection methods and implications for infection control.

Collins SJ, Lewis V, Brazier MW, Hill AF, Lawson VA, Klug GM, Masters CL. Collins SJ, et al. Neurobiol Dis. 2005 Nov;20(2):336-46. doi: 10.1016/j.nbd.2005.03.014. Neurobiol Dis. 2005. PMID: 16242640

8

Detection of prion epitopes on PrP and PrP of transmissible spongiform encephalopathies using specific monoclonal antibodies to PrP.

Yuan FF, Biffin S, Brazier MW, Suarez M, Cappai R, Hill AF, Collins SJ, Sullivan JS, Middleton D, Multhaup G, Geczy AF, Masters CL. Yuan FF, et al. Among authors: collins sj. Immunol Cell Biol. 2005 Dec;83(6):632-7. doi: 10.1111/j.1440-1711.2005.01384.x. Immunol Cell Biol. 2005. PMID: 16266315

9

Correlative studies support lipid peroxidation is linked to PrP(res) propagation as an early primary pathogenic event in prion disease.

Brazier MW, Lewis V, Ciccotosto GD, Klug GM, Lawson VA, Cappai R, Ironside JW, Masters CL, Hill AF, White AR, Collins S. Brazier MW, et al. Brain Res Bull. 2006 Jan 30;68(5):346-54. doi: 10.1016/j.brainresbull.2005.09.010. Epub 2005 Oct 5. Brain Res Bull. 2006. PMID: 16377442

10

A manganese-superoxide dismutase/catalase mimetic extends survival in a mouse model of human prion disease.

Brazier MW, Doctrow SR, Masters CL, Collins SJ. Brazier MW, et al. Among authors: collins sj. Free Radic Biol Med. 2008 Jul 15;45(2):184-92. doi: 10.1016/j.freeradbiomed.2008.04.006. Epub 2008 Apr 16. Free Radic Biol Med. 2008. PMID: 18455516

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

246 results

Search Page